Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TPST files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTempest Therapeutics presents clinical update at ISCT 2026 Annual Meeting
Filed May 6, 2026 · Period ending May 6, 2026 · ~1 min read
Key Changes
-
medium
Tempest issued a press release announcing a clinical update presentation at the ISCT 2026 Annual Meeting, though specific trial data or results were not disclosed in the 8-K filing itself.
Item 7.01 verify on EDGAR → -
low
The company posted an updated corporate presentation dated May 6, 2026 to its investor relations website as a routine Regulation FD disclosure to ensure equal access to company materials.
Item 7.01 verify on EDGAR →
Summary
Tempest Therapeutics filed an 8-K to disclose a clinical update presentation at the International Society for Cell & Gene Therapy (ISCT) 2026 Annual Meeting. The filing itself does not contain the actual clinical data or trial results presented, only that a presentation occurred and a press release was issued.
The company also posted an updated corporate presentation to its website as part of routine investor communications. For retail investors, this is a procedural filing that signals clinical activity but lacks substantive detail. The actual clinical data would be found in the attached press release (Exhibit 99.1) and corporate presentation (Exhibit 99.2), which are not summarized in the 8-K body.
Investors should review those exhibits directly to understand what clinical progress, if any, was announced. Watch for any follow-up disclosures or analyst commentary that interprets the clinical data presented at ISCT, as that will determine whether this update has material implications for Tempest's drug development pipeline.
Section-by-Section Diff
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On May 6, 2026, the Company issued a press release entitled “Tempest Presents Clinical Update at ISCT 2026 Annual Meeting.”
Tempest announced a clinical update presentation at the ISCT 2026 Annual Meeting through a press release. The 8-K does not provide details about the clinical data or trial results being presented, only that a presentation occurred.
Event · Item 9.01 — Financial Statements and Exhibits
Tempest Therapeutics filed an 8-K attaching a press release and corporate presentation dated May 2026.
Added in current filing · verify on EDGAR →
99.1 | Press release, dated May 6, 2026 | 99.2 | Corporate Presentation dated May 2026
The company filed exhibits including a press release dated May 6, 2026 and a corporate presentation dated May 2026. Without access to the actual exhibit content, the materiality and substance of these disclosures cannot be determined from the 8-K body alone.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify